At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Phorcides Analytical Enginedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Refractive Outcomes After Contoura® Refractive Surgery Planned Using Phorcides Surgery Planning Software
In Brief
An observational study evaluating Phorcides Analytical Engine for Refractive Errors. Completed, enrolled 70 participants across 5 sites.
Detailed Summary
The objective of the current study is to prospectively evaluate 3-month clinical outcomes from LASIK performed using the Phorcides surgical planning software with Contoura topography-guided ablation in both eyes of subjects with myopia and myopic astigmatism seeking refractive surgery for distance correction.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Errors
CountriesUnited States
CollaboratorsScience in Vision, Alcon Research
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJul 2020
First PostedAug 2020
Primary CompletionApr 2021
TodayJul 2026
First PostedAug 3, 2020
Enrollment StartJul 24, 2020
Primary CompletionApr 21, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.9 years ago
Interventions
Phorcides Analytical Enginedevice
Surgery planning using the Phorcides analytical engine.